Parkinson’s is the fastest growing neurological condition in the world and currently there is no cure. It affects around 153,000 people in the UK and every hour two more people are diagnosed.

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in ... continuous subcutaneous infusion of apomorphine delivered using the Apo-go pump, which has been ...

Jack Khattar; President, Chief Executive Officer, Secretary, Director; Supernus Pharmaceuticals Inc Timothy Dec; Chief Financial Officer, Senior Vice President; Supernus Pharmaceuticals Inc Good ...

Two of those – Xadago (safinamide) and Apokyn (apomorphine HCl) – are for Parkinson's disease, while the third (Myobloc) is a botulinum toxin product for cervical dystonia and chronic sialorrhea.

The Company will develop and commercialize SER-252 (POZ-apomorphine) in combination with enFuseTM for the treatment of Parkinson’s diseas HUNTSVILLE, July 29, 2024 (GLOBE NEWSWIRE ...

CBI says 11:13 AM UTC Lifestylecategory Musicians release silent album to protest UK's AI copyright changes 10:07 AM UTC United Kingdomcategory UK rules out trade deals which undercut food ...

Progressive supranuclear palsy. National Organization of Rare Disease. Fetal akinesia deformation sequence. University of Texas San Antonio. Parkinson's disease. National Health Service (UK).

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...

DAX Futures 22588.00 142.00 0.63% ...